Federated Hermes’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.1K | Sell |
39,736
-712,781
| -95% | -$827K | ﹤0.01% | 1643 |
|
|
2025
Q1 | $1.2M | Buy |
752,517
+258,535
| +52% | +$411K | ﹤0.01% | 1066 |
|
|
2024
Q4 | $1.5M | Buy |
493,982
+10,644
| +2% | +$32.3K | ﹤0.01% | 1004 |
|
|
2024
Q3 | $1.78M | Buy |
483,338
+857
| +0.2% | +$3.15K | ﹤0.01% | 956 |
|
|
2024
Q2 | $1.97M | Sell |
482,481
-1,516,219
| -76% | -$6.2M | ﹤0.01% | 927 |
|
|
2024
Q1 | $31.5M | Sell |
1,998,700
-161,865
| -7% | -$2.55M | 0.07% | 317 |
|
|
2023
Q4 | $32.7M | Buy |
2,160,565
+212,872
| +11% | +$3.23M | 0.08% | 279 |
|
|
2023
Q3 | $39.1M | Sell |
1,947,693
-70,541
| -3% | -$1.42M | 0.1% | 235 |
|
|
2023
Q2 | $56.9M | Buy |
2,018,234
+531,236
| +36% | +$15M | 0.14% | 183 |
|
|
2023
Q1 | $25.6M | Buy |
1,486,998
+275,398
| +23% | +$4.74M | 0.06% | 324 |
|
|
2022
Q4 | $24.4M | Buy |
1,211,600
+125,000
| +12% | +$2.52M | 0.07% | 337 |
|
|
2022
Q3 | $23.5M | Buy |
1,086,600
+1,461
| +0.1% | +$31.6K | 0.07% | 339 |
|
|
2022
Q2 | $30.5M | Buy |
1,085,139
+134,206
| +14% | +$3.77M | 0.08% | 294 |
|
|
2022
Q1 | $43.9M | Sell |
950,933
-23,727
| -2% | -$1.09M | 0.1% | 257 |
|
|
2021
Q4 | $81.9M | Sell |
974,660
-307,723
| -24% | -$25.9M | 0.15% | 187 |
|
|
2021
Q3 | $85.5M | Buy |
1,282,383
+7,717
| +0.6% | +$514K | 0.16% | 176 |
|
|
2021
Q2 | $67.8M | Sell |
1,274,666
-129,673
| -9% | -$6.9M | 0.13% | 212 |
|
|
2021
Q1 | $60.9M | Buy |
1,404,339
+625,264
| +80% | +$27.1M | 0.12% | 226 |
|
|
2020
Q4 | $40.5M | Hold |
779,075
| – | – | 0.08% | 297 |
|
|
2020
Q3 | $25.5M | Buy |
+779,075
| New | +$25.5M | 0.06% | 363 |
|